covid-oral-vaccine | Media Room

Tagged covid-oral-vaccine

Press Release Sep 7, 2022

BioLingus to Develop a Sublingual Vaccine for COVID in Cooperation With the Korean CHA Vaccine Institute and PanGen Biotech

Development of a sublingual COVID-19 subunit vaccine: the potential for a better protective efficacy and improved thermal stability during distribution and storage as compared to conventional COVID-19 vaccines

First
Prev

Next
Last